Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
EV/Net Sales

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Net Sales(x) 3.864.265.094.7311.50

What is the latest EV/Net Sales ratio of GLAND PHARMA ?

The latest EV/Net Sales ratio of GLAND PHARMA is 3.86 based on Mar2026 Consolidated results.
Year EV/Net Sales
Mar20263.86
Mar20254.26
Mar20245.09
Mar20234.73
Mar202211.50

How is EV/Net Sales of GLAND PHARMA Trending?

Years EV/Net Sales % Change
Mar2026 3.86
-9.39
Mar2025 4.26
-16.31
Mar2024 5.09
7.61
Mar2023 4.73
-58.87
Mar2022 11.5 -

Other Financial Ratios of GLAND PHARMA


Compare EV/Net Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹48,865.6 Cr 1.3% 2.2% 47.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.9% -5% 3.2% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr 3.6% -1.4% 37.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 1.7% -6.7% 28% Stock Analytics
CIPLA ₹109,063.0 Cr 2.8% -3.9% -17.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 5.4% 8.7% 1.6% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1.3%

2.2%

47.8%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses